Interim Vice Provost for Research Chief Research Compliance Officer
Ara Tahmassian, Ph.D., is currently the Interim Vice Provost for Research and Harvard University’s Chief Research Compliance Officer. In this role he is broadly responsible for the overall effort to manage potential risks at the University by integrating and coordinating the significant compliance requirements across the University. He is responsible for the oversight of the review, development, and implementation of policies related to research compliance activities across the University and management of University-wide Institutional Committees. He is also the Project Director for a Department of State Funded program for “Building University Capacity in Responsible Science for Broader Middle East and North Africa.”
Prior to Harvard University, Dr. Tahmassian was the Associate Vice President for Research Compliance at Boston University and Boston Medical Center, where he also served as the Principal Investigator for the core BSL-3 select agent laboratory and as one of the Associate Directors of the National Emerging Infectious Diseases Laboratories (NEIDL) at the BU Medical Campus.
He also served as the Associate Vice Chancellor for Research at University of California San Francisco in until his retirement in October 2006.
He has extensive experience in research compliance topics including Institutional Review Board; Environmental Health and Safety; Institutional Biosafety, Radiation Safety and Laboratory Safety; Dual User Research of Concern (DURC) oversight; Research Occupational Health Program; Animal Care and Use Programs; Financial Conflict of Interest; Responsible Conduct of Research and Sponsored Research Programs.
Dr. Tahmassian holds a B.Sc. in nuclear engineering and a Ph.D. in radiobiology from Queen Mary College, London University, and is a Diplomat of the American Board of Sciences in Nuclear Medicine. He serves on a number of national and international scientific and professional organizations.
M. William Lensch, Ph.D., is Associate Provost for Research. In this role, he works closely with the Vice Provost for Research (VPR) to support Harvard’s rich and complex, investigator-driven enterprise. His experience in research, education, administration, science policy, intellectual property, consulting and outreach combine in support of scientific discovery. He oversees a variety of strategic initiatives and develops key relationships – both within and beyond Harvard – to advance this research agenda including the many Interfaculty Initiatives (IFI) and cross-school curricular programs.
Prior to assuming his current role, Dr. Lensch was Strategic Advisor to the Dean of Harvard Medical School (HMS) and Executive Director of the Massachusetts Consortium on Pandemic Readiness (MassCPR), an HMS-led, multi-institutional response to the global COVID-19 pandemic. He has additionally served the Harvard community as Chief of Staff to the Dean of the Faculty of Medicine, Executive Director of the Department of Stem Cell and Regenerative Biology (SCRB), Faculty Director of Education for the Harvard Stem Cell Institute (HSCI), and as Instructor in Pediatrics at HMS/Boston Children’s Hospital.
He has contributed to more than 60 peer-reviewed articles, reviews, book chapters and policy recommendations, and presented over 200 lectures, medical grand rounds, interviews and panel discussions.
Dr. Lensch earned his B.S. in Biology from Utah State University and his Ph.D. in the Department of Molecular and Medical Genetics at Oregon Health Sciences University, where he studied pediatric bone marrow failure, the onset of myeloid leukemia and rare diseases of the blood. His post-doctoral work at the Whitehead Institute for Biomedical Research and as a Leukemia and Lymphoma Society Career-Development Fellow at Boston Children’s Hospital used various types of human cells and tissue as platforms for understanding the genetics, development and diseases of the blood-forming system.